183 related articles for article (PubMed ID: 23551961)
41. Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies.
Vayne C; Guéry EA; Charuel N; Besombes J; Lambert WC; Rollin J; Gruel Y; Pouplard C
J Thromb Haemost; 2020 Apr; 18(4):968-975. PubMed ID: 31997532
[TBL] [Abstract][Full Text] [Related]
42. Implementation of Whole-Blood Impedance Aggregometry for Heparin-Induced Thrombocytopenia Functional Assay and Case Discussion.
Jin J; Baker SA; Hall ET; Gombar S; Bao A; Zehnder JL
Am J Clin Pathol; 2019 Jun; 152(1):50-58. PubMed ID: 31165165
[TBL] [Abstract][Full Text] [Related]
43. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
44. Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities.
Warkentin TE; Sheppard JA; Chu FV; Kapoor A; Crowther MA; Gangji A
Blood; 2015 Jan; 125(1):195-8. PubMed ID: 25406354
[TBL] [Abstract][Full Text] [Related]
45. The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
Bissola AL; Daka M; Arnold DM; Smith JW; Moore JC; Clare R; Ivetic N; Kelton JG; Nazy I
Blood Adv; 2022 Jul; 6(14):4228-4235. PubMed ID: 35609563
[TBL] [Abstract][Full Text] [Related]
46. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
Lo GK; Sigouin CS; Warkentin TE
Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
[TBL] [Abstract][Full Text] [Related]
47. Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.
Andrews DM; Cubillos GF; Paulino SK; Seckinger DL; Kett DH
Crit Care; 2013 Jul; 17(4):R143. PubMed ID: 23876263
[TBL] [Abstract][Full Text] [Related]
48. Performance evaluation of heparin-induced platelet aggregation vs serotonin release assay.
Barouqa M; Matta M; Reyes-Gil M
Am J Clin Pathol; 2024 Feb; 161(2):122-129. PubMed ID: 37936260
[TBL] [Abstract][Full Text] [Related]
49. Pathogenic heparin-induced thrombocytopenia and thrombosis (HIT) antibodies determined by rapid functional flow cytometry.
Cipok M; Tomer A; Elalamy I; Kirgner I; Dror N; Kay S; Deutsch VR
Eur J Haematol; 2019 Sep; 103(3):225-233. PubMed ID: 31206215
[TBL] [Abstract][Full Text] [Related]
50. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
[TBL] [Abstract][Full Text] [Related]
51. Egyptian experience of reliability of 4T's score in diagnosis of heparin induced thrombocytopenia syndrome.
Tawfik NM; Hegazy MA; Hassan EA; Ramadan YK; Nasr AS
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):701-5. PubMed ID: 22008905
[TBL] [Abstract][Full Text] [Related]
52. Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia.
Asada R; Wanaka K; Walenga J; Prechel M; Miyashita K; Escalante V; Kaneko C; Hoshino N; Oosawa M; Matsuo M
Clin Appl Thromb Hemost; 2013; 19(1):37-41. PubMed ID: 22826445
[TBL] [Abstract][Full Text] [Related]
53. Evaluating the role for the optical density in the diagnosis of heparin-induced thrombocytopenia following cardiac surgery.
Chan CM; Corso PJ; Sun X; Hill PC; Shorr AF
Thromb Haemost; 2011 Nov; 106(5):934-8. PubMed ID: 21947303
[TBL] [Abstract][Full Text] [Related]
54. Heparin-induced thrombocytopenia: an improved method of detection based on lumi-aggregometry.
Stewart MW; Etches WS; Boshkov LK; Gordon PA
Br J Haematol; 1995 Sep; 91(1):173-7. PubMed ID: 7577628
[TBL] [Abstract][Full Text] [Related]
55. New platelet functional method for identification of pathogenic antibodies in HIT patients.
Guarino ML; Massimi I; Mardente S; Lappa A; Donfrancesco S; Visentin GP; Pulcinelli FM
Platelets; 2017 Nov; 28(7):728-730. PubMed ID: 28287032
[TBL] [Abstract][Full Text] [Related]
56. Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.
Warkentin TE; Sheppard JI; Smith JW; Arnold DM; Nazy I
Int J Lab Hematol; 2019 Aug; 41(4):493-502. PubMed ID: 31050876
[TBL] [Abstract][Full Text] [Related]
57. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
59. HITlights: a career perspective on heparin-induced thrombocytopenia.
Warkentin TE
Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
[TBL] [Abstract][Full Text] [Related]
60. Heparin-induced thrombocytopenia associated with interleukin-8-dependent platelet activation in a patient with antiphospholipid syndrome.
Bounameaux C; Boehlen F; Membré A; Genné D; Pouplard C; Regnault V; de Moerloose P
Eur J Haematol; 2007 Dec; 79(6):550-3. PubMed ID: 17961179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
